HSP90 inhibitor, 17-DMAG, alone and in combination with lapatinib attenuates acquired lapatinib-resistance in er-positive, her2-overexpressing breast cancer cell line

Hye Jin Lee, Seungho Shin, Jinho Kang, Ki Cheol Han, Yeul Hong Kim, Jeoung Won Bae, Kyong Hwa Park

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'HSP90 inhibitor, 17-DMAG, alone and in combination with lapatinib attenuates acquired lapatinib-resistance in er-positive, her2-overexpressing breast cancer cell line'. Together they form a unique fingerprint.

Medicine & Life Sciences